Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease
about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesThe role of oxidative stress in Parkinson's diseaseThe associations between Parkinson's disease and cancer: the plot thickensC-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.Parkinson's disease as a result of agingCopper active sites in biologyGenomewide association study for onset age in Parkinson disease.Quantitative photoacoustics to measure single cell melanin production and nanoparticle attachment.Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells.Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.Neuromelanin is an immune stimulator for dendritic cells in vitro.Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletionsIntrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CTThe evolution of dopamine systems in chordates.Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approachMelanocyte-secreted fibromodulin promotes an angiogenic microenvironment.Encapsulation of a reactive core in neuromelanin.Proteomics in neurodegenerative diseases: Methods for obtaining a closer look at the neuronal proteome.Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection.Neuromelanin in parkinsonian disorders: an update.Modifications of the iron-neuromelanin system in Parkinson's disease.Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.Direct intranigral injection of dopaminochrome causes degeneration of dopamine neuronsGenetics of iron regulation and the possible role of iron in Parkinson's disease.Genetic determinants of hair color and Parkinson's disease risk.Alpha-synuclein and Parkinson's disease: a proteomic view.Analysis of organelles within the nervous system: impact on brain and organelle functions.Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy.Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.Review: iron metabolism and the role of iron in neurodegenerative disorders.Evolutionary and biomedical consequences of internal melanins.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons.Proteomic studies associated with Parkinson's disease.Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.Photoprotection: extending lessons learned from studying natural sunscreens to the design of artificial sunscreen constituents.Habitual behavior and dopamine cell vulnerability in Parkinson disease.
P2860
Q24289511-EB8B7A89-088F-4B76-BEBE-A45BD60BF41DQ24307946-C049394D-1FCC-49A7-999D-41410B2C8B05Q26778641-C7ACB165-3C42-4EC7-B047-99EC92336592Q27931024-14E23C25-CE24-413A-9F36-6DF7F2E40218Q28084395-4C3C0168-1F86-4633-8CEB-FE12C684E715Q28658988-0F2CB47D-BA43-4299-951A-F901AF124CE0Q29417034-0E1A03CD-3290-4B8C-85AF-82DA777C070EQ30385484-E3DE6DE5-ECED-431E-9592-B04CBD7A4FB1Q30575408-255E8B68-ADF0-497F-9AA7-78CBDB204663Q33389875-78913918-7058-4215-B376-AA2DA0EA385AQ33850589-7B017EDE-8F81-4784-8771-D59C696069F7Q34032608-449E0AAC-0FD6-4C7B-A662-DCDE43D1FC36Q34074838-FFC0E15C-206E-474C-9EF2-4D2D4AE4B52FQ34107867-D5191715-37CA-448D-BCB7-CE06F8476A39Q34688815-1405CA2D-3DA8-4C54-B282-46F962B073EAQ34758213-01C1AB5C-8805-478A-A04D-94E379920355Q34968452-2F3E7AA9-EC81-497C-BAB8-9DD6259C75B5Q35072127-13002C04-6251-46AF-99A6-E3944281B4BEQ35075384-4093BA93-BC65-4529-B93C-DFF8135F7B07Q35241298-19172BE6-5E97-44BC-8DA5-55D376321999Q36191442-F25D7A3F-362E-415C-ABD0-03DC4E8D92D0Q36359956-E95F3338-7EE2-41B3-9035-60F023DA978DQ36370608-A5714424-76FF-4C4E-B565-E5E96BCE6AE6Q36373170-0EB4F7B9-D189-4475-B428-0D4C5D6CA379Q36505602-6C17A084-0791-4C11-BED9-EA9B8BF8FD53Q36815145-F858F9F3-DF45-46FB-A561-5D71D40CC529Q37091302-1170AF06-B006-4421-9618-4FFB8E995B5DQ37157838-B19E2238-A9EC-4565-BECF-64E2DB54550FQ37157865-438993BB-D63E-4DD0-902C-3E5597D79B89Q37171402-372748D1-8FCA-4951-99BA-4DE404364337Q37395786-846F6440-9CDD-4B7D-960C-26BC599EAEE4Q38155941-76C8C942-3761-4EC6-8047-FB7ECC7D45B9Q38213064-7235A170-6B34-483D-9AD6-2FCDFEFDF00BQ38669105-452607EB-4E9B-459A-9120-7424C1F1E140Q38721811-1F41D098-DECF-4E25-8FA6-8374F9CDFCA4Q38754535-337EEF3E-0FE6-4ABF-83AF-3B3282F5DB0BQ38761409-41BA5760-396B-4BBB-9EBB-D3FD5376F42CQ38921067-BD5F9AD2-7905-4FD7-939B-EDB89DA0AF67Q39350276-17FD3216-0C0A-4EDA-A1E9-46FE31EBC02FQ42177449-3AD96CFC-A950-4D6F-82C5-9DA0EE45FFC7
P2860
Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@ast
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@en
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@en-gb
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@nl
type
label
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@ast
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@en
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@en-gb
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@nl
altLabel
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@en
prefLabel
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@ast
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@en
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@en-gb
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@nl
P2093
P3181
P1476
Neuromelanin in human dopamine ...... levance to Parkinson's disease
@en
P2093
P304
P3181
P356
10.1016/J.PNEUROBIO.2005.02.001
P407
P577
2005-02-01T00:00:00Z